Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1071 of 5804
-
AI reads emotions to predict bipolar episodes
Knowledge-focused Recruiting nowBipolar disorder (BD) has become a significant public health problem with complex clinical manifestations, difficult treatment, and poor prognosis. However, there is still a lack of effective biological markers for diagnosing and predicting recurrence. Sentiment analysis computin…
Sponsor: Shanghai Mental Health Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
Could a new pill slow Alzheimer's? early trial begins
Disease control Recruiting nowThis early phase, open label, single arm clinical trial will determine the intraindividual safety, tolerability and effects of NPC1 (parthenolide and ipriflavone) on blood-based biomarkers of Alzheimer's disease (AD) pathology among adults with subjective cognitive decline, mild …
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New supplement cocktail aims to stop preterm labor
Prevention Recruiting nowThe aim of the study is to assess the effect of a combination of Magnesium, Palmitoylethanolamide, high-molecular-weight Hyaluronic Acid, Vitamin B6, and Vitamin D in women at risk of preterm birth (PTB).
Phase: NA • Sponsor: University of Roma La Sapienza • Aim: Prevention
Last updated Jun 27, 2026 12:24 UTC
-
Peer power: young moms lead HIV prevention in zimbabwe
Prevention Not yet recruitingThis is a pilot cluster-randomized control trial co-led by Dr. Valentina Cambiano, Associate Professor of Epidemiology at University College London, UK and Professor Euphemia Sibanda, Research Director at the Centre for Sexual Health and HIV Research (CeSHHAR Zimbabwe). The goal …
Phase: NA • Sponsor: University College, London • Aim: Prevention
Last updated Jun 27, 2026 12:23 UTC
-
AI heart scans could replace MRI for chemo patients
Diagnosis Not yet recruitingTo investigate the clinical utility of both 3D and 2D artificial intelligence reconstruction echocardiography (V-echo and L-echo) assessment against conventional echocardiography and clinical cardiovascular magnetic resonance (CMR) imaging for the characterisation of cardiac func…
Sponsor: The Royal Wolverhampton Hospitals NHS Trust • Aim: Diagnosis
Last updated Jun 27, 2026 09:04 UTC
-
Herbal-Antibiotic combo aims to beat stubborn womb infection
Disease control Not yet recruitingThis randomized, double-blind, single-dummy, multicenter clinical study, led by Principal Investigator Xue Fengxia at Tianjin Medical University General Hospital (sponsor and primary trial institution) and funded by Zhuzhou Qianjin Pharmaceutical Co., Ltd., evaluates the safety a…
Phase: PHASE4 • Sponsor: Tianjin Medical University • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Resilience training aims to shield first responders from PTSD
Prevention Not yet recruitingAs a result of chronic exposures to traumatic and stressful events, first responders are at elevated risk for experiencing post-traumatic stress disorder (PTSD) and other mental health problems. Resilience training can reduce the risk for developing mental health symptoms in firs…
Phase: NA • Sponsor: Stony Brook University • Aim: Prevention
Last updated Jun 27, 2026 12:10 UTC
-
New camera could slash skin cancer surgery time
Diagnosis Not yet recruitingBasal cell carcinoma (BCC) is the most common malignant skin tumour. The standard treatment is micrographically controlled surgery (MMS), which achieves high cure rates but requires considerable time and personnel. A key problem is the inadequate preoperative determination of tum…
Phase: NA • Sponsor: University Hospital Augsburg • Aim: Diagnosis
Last updated Jun 27, 2026 11:02 UTC
-
DNA-Guided depression treatment tested in morocco
Knowledge-focused Not yet recruitingThe purpose of this clinical trial is to evaluate whether using pharmacogenetic testing to guide antidepressant treatment can improve outcomes in adults with major depressive disorder in Morocco. Depression is a common mental health condition, and finding the most effective antid…
Phase: NA • Sponsor: Mohammed V University in Rabat • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
New drug duo aims to shrink tough lung cancer in 33-patient trial
Disease control Not yet recruitingThis is an single-arm, multicenter phase II study to evaluate the safety and efficacy of Sacituzumab Tirumotecan (sac-TMT) plus anlotinib in previously treated extensive-stage small cell lung cancer (ES-SCLC). The study is expected to enroll up to 33 eligible patients.
Phase: PHASE2 • Sponsor: Sichuan University • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Acupuncture vs. UTIs: new trial tests needle therapy to stop infections
Prevention Not yet recruitingThe goal of this clinical trial is to evaluate if electroacupuncture works to prevent recurrent lower urinary tract infections in female patients. It will also learn about the safety of electroacupuncture. The main questions it aims to answer are: 1. Does electroacupuncture redu…
Phase: NA • Sponsor: Yanjun Zhang, Baoyan Liu • Aim: Prevention
Last updated Jun 27, 2026 12:03 UTC
-
New study tests combo of low-dose drug and lifestyle to stop weight regain
Disease control Recruiting nowObesity is a chronic, progressive, and relapsing disease. Although lifestyle interventions and anti-obesity medications are effective for inducing weight loss, evidence regarding their role in long-term weight maintenance after pharmacologically induced weight reduction remains l…
Phase: NA • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Sound waves smash heart artery calcium in new trial
Disease control Not yet recruitingThe AERO CAD study is a prospective, multi-center, single-arm, post-market clinical investigation evaluating the procedural performance and clinical outcomes of the Shockwave C2 Aero Coronary Intravascular Lithotripsy (IVL) System in patients with calcified coronary artery diseas…
Phase: NA • Sponsor: OPCI Core Laboratories LLC • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Could a common drug prevent brain swelling after stroke?
Disease control Not yet recruitingThis is a prospective, multicenter, randomized controlled clinical study aimed at evaluating the efficacy of butylphthalide in improving the severity of cerebral edema and prognosis in patients with acute anterior circulation large vessel occlusion after endovascular treatment.
Phase: PHASE4 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Can a tiny zing at your fingertips wake the brain? new trial aims to find out
Symptom relief Not yet recruitingEffective treatment options for disorders of consciousness (DoC) remain limited, and available interventions show heterogeneous efficacy. To date, limited evidences support the use of amantadine and transcranial direct current stimulation in this population. Bloodletting punctur…
Phase: PHASE2, PHASE3 • Sponsor: Xijing Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
New surgery aims to remove stomach tumors without major incisions
Disease control ENROLLING_BY_INVITATIONThis study is a single-center, prospective, single-arm, exploratory clinical study (phase II exploratory trial). No parallel control group was established in the study, and all subjects who met the inclusion criteria underwent a uniform surgical treatment approach, namely, double…
Phase: PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Can early radiation stop cancer bone breaks?
Disease control Not yet recruitingThis is a prospective, randomized, single-center clinical trial evaluating whether early prophylactic radiotherapy to high-risk asymptomatic or minimally symptomatic bone metastases reduces the 1-year rate of skeletal-related events (SREs) in patients with metastatic solid cancer…
Phase: PHASE2 • Sponsor: Institute of Oncology Ljubljana • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
Blood test could predict chronic GVHD after transplant
Knowledge-focused Not yet recruitingThis study is a single-center observational clinical study. Participants were enrolled as two cohorts of patients including discovery cohort and validation cohort. A total of consecutive 1000 patients receiving allo-HSCT in our center from 2021.01 to 2023.06 were retrospectively …
Phase: NA • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC
-
New device aims to seal brain aneurysms without surgery
Disease control Not yet recruitingThe objective of this study is to investgiate the safety and clinical performance of the World Diverter Emoblization Device for the endovascular treatment of wide-neck (neck width ≥ 4 mm or dome-to-neck ratio \<2) or fusiform intracranial aneurysms in the internal carotid artery …
Phase: NA • Sponsor: World Medica USA, LLC • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New antibody EPI-326 enters first human trials for tough cancers
Disease control Recruiting nowA phase 1 study to determine the safety, tolerability, PK, PD, and preliminary anti-tumor activity of ascending doses of EPI-326 administered to patients with locally advanced or metastatic HNSCC and to patients with any documented EGFR-mutant locally advanced or metastatic NSCLC…
Phase: PHASE1 • Sponsor: EpiBiologics • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC